AUM $176.1MER 0.50%NAV $52.56Holdings 103Inception Dec 2014
Price Chart
Key Statistics
Previous Close
$52.53Day Range
$50.87$52.87
52-Week Range
$47.70$70.79
Avg Volume
26.9KDividend Yield
2.29%Expense Ratio
0.50%AUM
$176.1MShares Outstanding
3.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 92.07% |
| Canada | 2.53% |
| China | 1.78% |
| Netherlands | 1.62% |
| United Kingdom | 1.48% |
| Switzerland | 0.32% |
| Belgium | 0.19% |
Fund Information
- Issuer
- ALPS Funds
- Category
- Healthcare
- Types
- Healthcare
- Inception Date
- Dec 30, 2014
- Exchange
- NYSE_ARCA
- Description
- The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
Similar ETFs
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $176.1M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 32.9% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | CGON | CG oncology Inc. | 5.04% | 108,350 | $8.9M |
| 2 | ORKA | Oruka Therapeutics Inc. | 4.49% | 80,990 | $7.9M |
| 3 | MANE | VeraDermics Inc. | 3.61% | 51,154 | $6.4M |
| 4 | DNTH | Dianthus Therapeutics Inc. | 3.30% | 68,461 | $5.8M |
| 5 | TVTX | Travere Therapeutics Inc. | 3.16% | 115,122 | $5.6M |
| 6 | EWTX | Edgewise Therapeutics Inc. | 3.10% | 132,752 | $5.5M |
| 7 | DFTX | Definium Therapeutics Inc. | 2.75% | 164,209 | $4.8M |
| 8 | XENE | Xenon Pharmaceuticals Inc. | 2.53% | 118,559 | $4.5M |
| 9 | VRDN | Viridian Therapeutics Inc. | 2.48% | 138,693 | $4.4M |
| 10 | RLAY | Relay Therapeutics Inc. | 2.42% | 268,304 | $4.3M |
| 11 | TARS | Tarsus Pharmaceuticals Inc. | 2.37% | 53,719 | $4.2M |
| 12 | AMLX | Amylyx Pharmaceuticals Inc. | 2.29% | 153,697 | $4.0M |
| 13 | ACAD | ACADIA Pharmaceuticals Inc. | 2.10% | 210,497 | $3.7M |
| 14 | SLS | SELLAS Life Sciences Group Inc. | 2.09% | 247,255 | $3.7M |
| 15 | DYN | Dyne Therapeutics Inc. | 2.08% | 228,641 | $3.7M |
Page 1 of 3
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -3.16% | |
| 1W | -5.42% | |
| 1M | -4.56% | |
| 3M | -25.77% | |
| 6M | -4.86% | |
| YTD | +1.57% | |
| 1Y | +5.66% | |
| 3Y | +99.22% | |
| 5Y | +15.26% |
Moving Averages
20-Day MA
$54.86
Below 20-Day MA50-Day MA
$56.05
Below 50-Day MA200-Day MA
$57.24
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$70.79
Current Price
$50.87
52-Week Low
$47.70
$47.70$70.79
Current Yield
2.29%
Annual Dividend
$1.2764
Frequency
1x/year
Last Ex-Date
Dec 19, 2024
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 19, 2024 | $1.1735 | Dec 26, 2024 |
| Dec 21, 2023 | $0.0711 | Dec 27, 2023 |
| Dec 19, 2019 | $0.0160 | Dec 27, 2019 |
| Dec 19, 2019 | $0.0158 | Dec 27, 2019 |
| Dec 20, 2018 | $0.7841 | Dec 27, 2018 |
| Dec 20, 2018 | $0.7840 | Dec 27, 2018 |
| Dec 21, 2017 | $0.5795 | Dec 28, 2017 |
| Dec 21, 2017 | $0.5790 | Dec 28, 2017 |
Dividend Payments Over Time
Category Comparison
| Metric | SBIO | Healthcare(212 ETFs) | Healthcare(24 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.50% | 0.68% | 0.47% |
| AUM | $176.1M | $842.0M | $840.0M |
| Dividend Yield | 2.29% | 5.54% | 1.58% |
| Avg Volume | 26.9K | 257.4K | 176.4K |
| Holdings | 103 | 124 | 172 |
| Performance | |||
| 1-Month Return | -6.60% | -7.05% | -3.70% |
| 6-Month Return | +0.85% | -1.75% | +4.92% |
| YTD Return | -0.53% | +2.72% | +5.77% |
| 1-Year Return | -0.73% | +0.26% | +4.66% |
Compare with Another ETF
Search for an ETF to compare with SBIO:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.